Design of CRASH trial. Evidence shows that quality of trial by Faupel et al is good and therefore should not be excluded

BMJ. 1999 Oct 16;319(7216):1068. doi: 10.1136/bmj.319.7216.1068a.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use*
  • Brain Injuries / drug therapy*
  • Clinical Trials as Topic* / standards
  • Humans

Substances

  • Adrenal Cortex Hormones